25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Tourmaline Bio Inc.
Buy, Hold or Sell?

Let's analyze Tourmaline Bio Inc. together

I guess you are interested in Tourmaline Bio Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tourmaline Bio Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Tourmaline Bio Inc.

I send you an email if I find something interesting about Tourmaline Bio Inc..

1. Quick Overview

1.1. Quick analysis of Tourmaline Bio Inc. (30 sec.)










1.2. What can you expect buying and holding a share of Tourmaline Bio Inc.? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$12.46
Expected worth in 1 year
$19.35
How sure are you?
38.5%

+ What do you gain per year?

Total Gains per Share
$6.89
Return On Investment
56.4%

For what price can you sell your share?

Current Price per Share
$12.21
Expected price per share
$9.18 - $19.14
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Tourmaline Bio Inc. (5 min.)




Live pricePrice per Share (EOD)
$12.21
Intrinsic Value Per Share
$-37.12 - $-43.89
Total Value Per Share
$-24.66 - $-31.42

2.2. Growth of Tourmaline Bio Inc. (5 min.)




Is Tourmaline Bio Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$321m$60.5m$244m80.1%

How much money is Tourmaline Bio Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$12.2m-$7.6m-$4.5m-37.3%
Net Profit Margin23.4%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Tourmaline Bio Inc. (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Tourmaline Bio Inc.?

Welcome investor! Tourmaline Bio Inc.'s management wants to use your money to grow the business. In return you get a share of Tourmaline Bio Inc..

First you should know what it really means to hold a share of Tourmaline Bio Inc.. And how you can make/lose money.

Speculation

The Price per Share of Tourmaline Bio Inc. is $12.21. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tourmaline Bio Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tourmaline Bio Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $12.46. Based on the TTM, the Book Value Change Per Share is $1.72 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.51 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tourmaline Bio Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.78-6.4%-0.47-3.9%-0.30-2.4%-0.32-2.6%-0.32-2.6%
Usd Book Value Change Per Share-0.69-5.7%1.7214.1%-0.51-4.2%0.967.9%0.967.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.69-5.7%1.7214.1%-0.51-4.2%0.967.9%0.967.9%
Usd Price Per Share25.71-21.91-2.19-10.94-10.94-
Price to Earnings Ratio-8.21-13.74--333.60--19,320.08--19,320.08-
Price-to-Total Gains Ratio-37.26--10.50-0.04--7.53--7.53-
Price to Book Ratio2.06-1.99--0.59-0.82-0.82-
Price-to-Total Gains Ratio-37.26--10.50-0.04--7.53--7.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.21
Number of shares81
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.720.96
Usd Total Gains Per Share1.720.96
Gains per Quarter (81 shares)139.5077.64
Gains per Year (81 shares)557.98310.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105585480311301
20111611060621612
30167416640932923
4022322222012421234
5027902780015531545
6033483338018631856
7039063896021742167
8044644454024842478
9050225012027952789
10055805570031063100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.012.00.07.7%1.012.00.07.7%1.012.00.07.7%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%5.08.00.038.5%5.08.00.038.5%5.08.00.038.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%5.08.00.038.5%5.08.00.038.5%5.08.00.038.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Tourmaline Bio Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.6901.722-140%-0.507-27%0.958-172%0.958-172%
Book Value Per Share--12.46011.854+5%2.363+427%7.765+60%7.765+60%
Current Ratio--40.33347.782-16%14.010+188%31.439+28%31.439+28%
Debt To Asset Ratio--0.0220.020+12%1.188-98%0.387-94%0.387-94%
Debt To Equity Ratio--0.0230.021+12%0.031-26%0.032-29%0.032-29%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--937014570.000823778754.500+14%112632687.500+732%461438855.846+103%461438855.846+103%
Eps---0.783-0.475-39%-0.299-62%-0.320-59%-0.320-59%
Ev To Ebitda Ratio---9.590-14.912+56%-74.326+675%-30.289+216%-30.289+216%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.910-0.441-52%-0.409-55%-0.476-48%-0.476-48%
Free Cash Flow To Equity Per Share---0.9102.658-134%-0.405-55%0.478-290%0.478-290%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---43.885--------
Intrinsic Value_10Y_min---37.123--------
Intrinsic Value_1Y_max---2.284--------
Intrinsic Value_1Y_min---2.242--------
Intrinsic Value_3Y_max---8.473--------
Intrinsic Value_3Y_min---8.057--------
Intrinsic Value_5Y_max---16.605--------
Intrinsic Value_5Y_min---15.274--------
Market Cap313096146.000-112%662469570.000562954754.500+18%56093187.500+1081%280876317.385+136%280876317.385+136%
Net Profit Margin---0.234-100%-0%0.072-100%0.072-100%
Operating Margin----0.6590%-0%-0.2030%-0.2030%
Operating Ratio---0.819-100%-0%0.252-100%0.252-100%
Pb Ratio0.980-111%2.0631.993+4%-0.589+129%0.816+153%0.816+153%
Pe Ratio-3.898+53%-8.20813.744-160%-333.605+3964%-19320.080+235275%-19320.080+235275%
Price Per Share12.210-111%25.71021.913+17%2.188+1075%10.941+135%10.941+135%
Price To Free Cash Flow Ratio-3.355+53%-7.064-1.567-78%-2.182-69%-2.944-58%-2.944-58%
Price To Total Gains Ratio-17.695+53%-37.260-10.501-72%0.038-98942%-7.529-80%-7.529-80%
Quick Ratio--72.60376.672-5%56.034+30%64.059+13%64.059+13%
Return On Assets---0.061-0.035-43%-0.067+8%-0.039-36%-0.039-36%
Return On Equity---0.063-0.035-44%-0.024-62%-0.027-58%-0.027-58%
Total Gains Per Share---0.6901.722-140%-0.507-27%0.958-172%0.958-172%
Usd Book Value--321068000.000304632750.000+5%60586000.000+430%199305538.462+61%199305538.462+61%
Usd Book Value Change Per Share---0.6901.722-140%-0.507-27%0.958-172%0.958-172%
Usd Book Value Per Share--12.46011.854+5%2.363+427%7.765+60%7.765+60%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--937014570.000823778754.500+14%112632687.500+732%461438855.846+103%461438855.846+103%
Usd Eps---0.783-0.475-39%-0.299-62%-0.320-59%-0.320-59%
Usd Free Cash Flow---23444000.000-11338250.500-52%-10485374.250-55%-12225346.077-48%-12225346.077-48%
Usd Free Cash Flow Per Share---0.910-0.441-52%-0.409-55%-0.476-48%-0.476-48%
Usd Free Cash Flow To Equity Per Share---0.9102.658-134%-0.405-55%0.478-290%0.478-290%
Usd Market Cap313096146.000-112%662469570.000562954754.500+18%56093187.500+1081%280876317.385+136%280876317.385+136%
Usd Price Per Share12.210-111%25.71021.913+17%2.188+1075%10.941+135%10.941+135%
Usd Profit---20177000.000-12212250.000-39%-7662730.000-62%-8207438.538-59%-8207438.538-59%
Usd Revenue---569000.000-100%-0%175076.923-100%175076.923-100%
Usd Total Gains Per Share---0.6901.722-140%-0.507-27%0.958-172%0.958-172%
 EOD+3 -5MRQTTM+12 -24YOY+15 -175Y+15 -2110Y+15 -21

3.3 Fundamental Score

Let's check the fundamental score of Tourmaline Bio Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.898
Price to Book Ratio (EOD)Between0-10.980
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than172.603
Current Ratio (MRQ)Greater than140.333
Debt to Asset Ratio (MRQ)Less than10.022
Debt to Equity Ratio (MRQ)Less than10.023
Return on Equity (MRQ)Greater than0.15-0.063
Return on Assets (MRQ)Greater than0.05-0.061
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Tourmaline Bio Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.266
Ma 20Greater thanMa 5014.721
Ma 50Greater thanMa 10018.245
Ma 100Greater thanMa 20022.250
OpenGreater thanClose12.640
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Tourmaline Bio Inc.

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2025-02-17 00:25:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Tourmaline Bio Inc. earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Tourmaline Bio Inc. to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tourmaline Bio Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM23.4%-23.4%
TTM23.4%YOY-+23.4%
TTM23.4%5Y7.2%+16.2%
5Y7.2%10Y7.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--101.1%+101.1%
TTM23.4%-211.5%+234.9%
YOY--209.8%+209.8%
5Y7.2%-347.8%+355.0%
10Y7.2%-490.6%+497.8%
4.3.1.2. Return on Assets

Shows how efficient Tourmaline Bio Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tourmaline Bio Inc. to the Biotechnology industry mean.
  • -6.1% Return on Assets means that Tourmaline Bio Inc. generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tourmaline Bio Inc.:

  • The MRQ is -6.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.1%TTM-3.5%-2.7%
TTM-3.5%YOY-6.7%+3.2%
TTM-3.5%5Y-3.9%+0.5%
5Y-3.9%10Y-3.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.1%-11.9%+5.8%
TTM-3.5%-12.1%+8.6%
YOY-6.7%-11.4%+4.7%
5Y-3.9%-12.8%+8.9%
10Y-3.9%-14.5%+10.6%
4.3.1.3. Return on Equity

Shows how efficient Tourmaline Bio Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tourmaline Bio Inc. to the Biotechnology industry mean.
  • -6.3% Return on Equity means Tourmaline Bio Inc. generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tourmaline Bio Inc.:

  • The MRQ is -6.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-3.5%-2.7%
TTM-3.5%YOY-2.4%-1.2%
TTM-3.5%5Y-2.7%-0.9%
5Y-2.7%10Y-2.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-15.4%+9.1%
TTM-3.5%-16.1%+12.6%
YOY-2.4%-14.7%+12.3%
5Y-2.7%-18.4%+15.7%
10Y-2.7%-19.4%+16.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Tourmaline Bio Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Tourmaline Bio Inc. is operating .

  • Measures how much profit Tourmaline Bio Inc. makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tourmaline Bio Inc. to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tourmaline Bio Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-65.9%+65.9%
TTM-65.9%YOY--65.9%
TTM-65.9%5Y-20.3%-45.6%
5Y-20.3%10Y-20.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--202.6%+202.6%
TTM-65.9%-312.9%+247.0%
YOY--215.9%+215.9%
5Y-20.3%-373.0%+352.7%
10Y-20.3%-494.3%+474.0%
4.3.2.2. Operating Ratio

Measures how efficient Tourmaline Bio Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tourmaline Bio Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.819-0.819
TTM0.819YOY-+0.819
TTM0.8195Y0.252+0.567
5Y0.25210Y0.2520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.129-2.129
TTM0.8193.198-2.379
YOY-3.394-3.394
5Y0.2524.844-4.592
10Y0.2526.520-6.268
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Tourmaline Bio Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Tourmaline Bio Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 40.33 means the company has $40.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tourmaline Bio Inc.:

  • The MRQ is 40.333. The company is very able to pay all its short-term debts. +2
  • The TTM is 47.782. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ40.333TTM47.782-7.450
TTM47.782YOY14.010+33.772
TTM47.7825Y31.439+16.344
5Y31.43910Y31.4390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ40.3333.586+36.747
TTM47.7823.865+43.917
YOY14.0104.600+9.410
5Y31.4395.973+25.466
10Y31.4396.222+25.217
4.4.3.2. Quick Ratio

Measures if Tourmaline Bio Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tourmaline Bio Inc. to the Biotechnology industry mean.
  • A Quick Ratio of 72.60 means the company can pay off $72.60 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tourmaline Bio Inc.:

  • The MRQ is 72.603. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 76.672. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ72.603TTM76.672-4.069
TTM76.672YOY56.034+20.638
TTM76.6725Y64.059+12.613
5Y64.05910Y64.0590.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ72.6033.075+69.528
TTM76.6723.349+73.323
YOY56.0344.394+51.640
5Y64.0595.990+58.069
10Y64.0596.478+57.581
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Tourmaline Bio Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Tourmaline Bio Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tourmaline Bio Inc. to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.02 means that Tourmaline Bio Inc. assets are financed with 2.2% credit (debt) and the remaining percentage (100% - 2.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tourmaline Bio Inc.:

  • The MRQ is 0.022. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.020. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.022TTM0.020+0.002
TTM0.020YOY1.188-1.167
TTM0.0205Y0.387-0.367
5Y0.38710Y0.3870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0220.344-0.322
TTM0.0200.346-0.326
YOY1.1880.314+0.874
5Y0.3870.364+0.023
10Y0.3870.384+0.003
4.5.4.2. Debt to Equity Ratio

Measures if Tourmaline Bio Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tourmaline Bio Inc. to the Biotechnology industry mean.
  • A Debt to Equity ratio of 2.3% means that company has $0.02 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tourmaline Bio Inc.:

  • The MRQ is 0.023. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.021. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.023TTM0.021+0.002
TTM0.021YOY0.031-0.011
TTM0.0215Y0.032-0.012
5Y0.03210Y0.0320.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0230.393-0.370
TTM0.0210.428-0.407
YOY0.0310.391-0.360
5Y0.0320.451-0.419
10Y0.0320.496-0.464
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Tourmaline Bio Inc. generates.

  • Above 15 is considered overpriced but always compare Tourmaline Bio Inc. to the Biotechnology industry mean.
  • A PE ratio of -8.21 means the investor is paying $-8.21 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tourmaline Bio Inc.:

  • The EOD is -3.898. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.208. Based on the earnings, the company is expensive. -2
  • The TTM is 13.744. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-3.898MRQ-8.208+4.310
MRQ-8.208TTM13.744-21.952
TTM13.744YOY-333.605+347.349
TTM13.7445Y-19,320.080+19,333.824
5Y-19,320.08010Y-19,320.0800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.898-2.321-1.577
MRQ-8.208-2.797-5.411
TTM13.744-3.222+16.966
YOY-333.605-3.381-330.224
5Y-19,320.080-6.130-19,313.950
10Y-19,320.080-6.742-19,313.338
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tourmaline Bio Inc.:

  • The EOD is -3.355. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.064. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.567. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.355MRQ-7.064+3.709
MRQ-7.064TTM-1.567-5.498
TTM-1.567YOY-2.182+0.616
TTM-1.5675Y-2.944+1.378
5Y-2.94410Y-2.9440.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.355-3.066-0.289
MRQ-7.064-3.619-3.445
TTM-1.567-3.819+2.252
YOY-2.182-4.445+2.263
5Y-2.944-8.237+5.293
10Y-2.944-9.232+6.288
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Tourmaline Bio Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.06 means the investor is paying $2.06 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Tourmaline Bio Inc.:

  • The EOD is 0.980. Based on the equity, the company is cheap. +2
  • The MRQ is 2.063. Based on the equity, the company is underpriced. +1
  • The TTM is 1.993. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.980MRQ2.063-1.083
MRQ2.063TTM1.993+0.070
TTM1.993YOY-0.589+2.582
TTM1.9935Y0.816+1.178
5Y0.81610Y0.8160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9801.937-0.957
MRQ2.0632.236-0.173
TTM1.9932.402-0.409
YOY-0.5892.471-3.060
5Y0.8163.769-2.953
10Y0.8164.522-3.706
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Tourmaline Bio Inc..

4.8.3. Insider Transactions

Insiders are holding 22.617% of the shares of Tourmaline Bio Inc..

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-08-16Sandeep Chidambar KulkarniBUY522113.79
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets328,447
Total Liabilities7,379
Total Stockholder Equity321,068
 As reported
Total Liabilities 7,379
Total Stockholder Equity+ 321,068
Total Assets = 328,447

Assets

Total Assets328,447
Total Current Assets293,785
Long-term Assets34,662
Total Current Assets
Cash And Cash Equivalents 35,008
Short-term Investments 246,916
Other Current Assets 11,861
Total Current Assets  (as reported)293,785
Total Current Assets  (calculated)293,785
+/-0
Long-term Assets
Property Plant Equipment 307
Long Term Investments 32,467
Long-term Assets Other 1,888
Long-term Assets  (as reported)34,662
Long-term Assets  (calculated)34,662
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,284
Long-term Liabilities95
Total Stockholder Equity321,068
Total Current Liabilities
Short-term Debt 226
Accounts payable 2,054
Other Current Liabilities 5,004
Total Current Liabilities  (as reported)7,284
Total Current Liabilities  (calculated)7,284
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt64
Long-term Liabilities Other 31
Long-term Liabilities  (as reported)95
Long-term Liabilities  (calculated)95
+/-0
Total Stockholder Equity
Common Stock3
Retained Earnings -113,026
Accumulated Other Comprehensive Income 821
Other Stockholders Equity 433,270
Total Stockholder Equity (as reported)321,068
Total Stockholder Equity (calculated)321,068
+/-0
Other
Capital Stock3
Cash and Short Term Investments 281,924
Common Stock Shares Outstanding 25,767
Liabilities and Stockholders Equity 328,447
Net Debt -34,718
Net Invested Capital 321,068
Net Working Capital 286,501
Property Plant and Equipment Gross 307
Short Long Term Debt Total 290



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
> Total Assets 
261,325
251,422
237,246
220,916
206,544
9,098
172,607
91,605
151,061
210,295
359,169
344,791
328,447
328,447344,791359,169210,295151,06191,605172,6079,098206,544220,916237,246251,422261,325
   > Total Current Assets 
258,227
246,514
228,418
212,037
197,960
8,312
168,860
88,544
151,047
208,874
300,099
298,127
293,785
293,785298,127300,099208,874151,04788,544168,8608,312197,960212,037228,418246,514258,227
       Cash And Cash Equivalents 
27,311
18,614
22,791
25,518
18,468
8,258
24,224
87,090
67,083
140,726
98,286
70,148
35,008
35,00870,14898,286140,72667,08387,09024,2248,25818,46825,51822,79118,61427,311
       Short-term Investments 
227,423
225,357
202,738
181,594
175,401
167,612
141,589
133,901
79,941
62,225
194,773
219,385
246,916
246,916219,385194,77362,22579,941133,901141,589167,612175,401181,594202,738225,357227,423
       Net Receivables 
0
0
0
0
0
0
0
0
1,350
0
0
0
0
00001,35000000000
       Other Current Assets 
3,493
2,543
2,889
4,925
4,091
54
3,047
1
1,494
5,923
7,040
8,594
11,861
11,8618,5947,0405,9231,49413,047544,0914,9252,8892,5433,493
   > Long-term Assets 
3,098
4,908
8,828
8,879
8,584
786
3,747
3,061
14
1,421
59,070
46,664
34,662
34,66246,66459,0701,421143,0613,7477868,5848,8798,8284,9083,098
       Property Plant Equipment 
2,994
4,804
8,717
8,768
8,306
570
3,636
521
0
447
402
355
307
30735540244705213,6365708,3068,7688,7174,8042,994
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
57,237
44,878
32,467
32,46744,87857,2370000000000
       Long-term Assets Other 
104
104
111
111
278
216
111
2,290
14
63,137
1,431
1,204
1,888
1,8881,2041,43163,137142,290111216278111111104104
> Total Liabilities 
5,676
8,613
11,216
10,174
11,677
28,830
10,876
134,134
8,187
5,253
5,030
6,509
7,379
7,3796,5095,0305,2538,187134,13410,87628,83011,67710,17411,2168,6135,676
   > Total Current Liabilities 
4,982
7,987
8,065
7,331
9,168
1,363
10,179
6,016
8,105
5,002
4,827
6,361
7,284
7,2846,3614,8275,0028,1056,01610,1791,3639,1687,3318,0657,9874,982
       Short-term Debt 
0
0
740
835
905
162
751
218
634
442
223
448
226
22644822344263421875116290583574000
       Accounts payable 
1,182
2,556
3,485
2,075
2,133
401
3,384
2,429
136
1,071
1,936
2,387
2,054
2,0542,3871,9361,0711362,4293,3844012,1332,0753,4852,5561,182
       Other Current Liabilities 
3,800
5,431
3,840
4,421
6,130
1
6,044
45
47
3,489
2,668
3,526
5,004
5,0043,5262,6683,48947456,04416,1304,4213,8405,4313,800
   > Long-term Liabilities 
694
626
3,151
2,843
2,509
27,467
697
128,118
82
251
203
148
95
9514820325182128,11869727,4672,5092,8433,151626694
> Total Stockholder Equity
255,649
242,809
226,030
210,742
194,867
-19,732
161,731
-42,529
142,874
205,042
354,139
338,282
321,068
321,068338,282354,139205,042142,874-42,529161,731-19,732194,867210,742226,030242,809255,649
   Common Stock
4
4
4
4
4
4
4
1
0
2
3
3
3
3332014444444
   Retained Earnings -113,026-92,849-75,362-62,051-208,991-43,558-187,238-19,927-146,213-127,202-109,106-90,847-76,606
   Accumulated Other Comprehensive Income 
29
-78
-926
-1,143
-1,222
-721
-299
899
-115
67
-253
-452
821
821-452-25367-115899-299-721-1,222-1,143-926-7829
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
332,222
333,730
336,058
339,083
342,298
885
322,139
1
351,852
267,024
429,751
431,580
433,270
433,270431,580429,751267,024351,8521322,139885342,298339,083336,058333,730332,222



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-33
Gross Profit-33-33
 
Operating Income (+$)
Gross Profit-33
Operating Expense-45,409
Operating Income-45,409-45,442
 
Operating Expense (+$)
Research Development32,368
Selling General Administrative13,041
Selling And Marketing Expenses0
Operating Expense45,40945,409
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-45,409
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-42,124-48,694
EBIT - interestExpense = -45,409
-42,124
-42,124
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-45,409-42,124
Earnings Before Interest and Taxes (EBITDA)-45,376
 
After tax Income (+$)
Income Before Tax-42,124
Tax Provision-0
Net Income From Continuing Ops-42,124-42,124
Net Income-42,124
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses45,409
Total Other Income/Expenses Net3,2850
 

Technical Analysis of Tourmaline Bio Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tourmaline Bio Inc.. The general trend of Tourmaline Bio Inc. is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tourmaline Bio Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tourmaline Bio Inc..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 15.24 < 16.60 < 19.14.

The bearish price targets are: 12.12 > 9.5501148325359 > 9.18.

Tweet this
Tourmaline Bio Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tourmaline Bio Inc.. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tourmaline Bio Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tourmaline Bio Inc.. The current macd is -1.73267274.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tourmaline Bio Inc. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tourmaline Bio Inc.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tourmaline Bio Inc. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tourmaline Bio Inc. Daily Moving Average Convergence/Divergence (MACD) ChartTourmaline Bio Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tourmaline Bio Inc.. The current adx is 44.08.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tourmaline Bio Inc. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Tourmaline Bio Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tourmaline Bio Inc.. The current sar is 14.48.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tourmaline Bio Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tourmaline Bio Inc.. The current rsi is 25.27. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Tourmaline Bio Inc. Daily Relative Strength Index (RSI) ChartTourmaline Bio Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tourmaline Bio Inc.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tourmaline Bio Inc. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Tourmaline Bio Inc. Daily Stochastic Oscillator ChartTourmaline Bio Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tourmaline Bio Inc.. The current cci is -104.07439798.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Tourmaline Bio Inc. Daily Commodity Channel Index (CCI) ChartTourmaline Bio Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tourmaline Bio Inc.. The current cmo is -53.04187743.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tourmaline Bio Inc. Daily Chande Momentum Oscillator (CMO) ChartTourmaline Bio Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tourmaline Bio Inc.. The current willr is -98.21029083.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Tourmaline Bio Inc. Daily Williams %R ChartTourmaline Bio Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tourmaline Bio Inc..

Tourmaline Bio Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tourmaline Bio Inc.. The current atr is 0.94096351.

Tourmaline Bio Inc. Daily Average True Range (ATR) ChartTourmaline Bio Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tourmaline Bio Inc.. The current obv is -3,250,105.

Tourmaline Bio Inc. Daily On-Balance Volume (OBV) ChartTourmaline Bio Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tourmaline Bio Inc.. The current mfi is 33.71.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tourmaline Bio Inc. Daily Money Flow Index (MFI) ChartTourmaline Bio Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tourmaline Bio Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Tourmaline Bio Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tourmaline Bio Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.266
Ma 20Greater thanMa 5014.721
Ma 50Greater thanMa 10018.245
Ma 100Greater thanMa 20022.250
OpenGreater thanClose12.640
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Tourmaline Bio Inc. with someone you think should read this too:
  • Are you bullish or bearish on Tourmaline Bio Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tourmaline Bio Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tourmaline Bio Inc.

I send you an email if I find something interesting about Tourmaline Bio Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Tourmaline Bio Inc..

Receive notifications about Tourmaline Bio Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.